新產(chǎn)品·新技術(shù)信息

芬歐藍(lán)泰在PharmaPack上推出一系列藥品標(biāo)簽解決方案

來源：林中祥膠粘劑技術(shù)信息網(wǎng)2015年02月14日

閱讀次數(shù)：次

UPM Raflatac at PharmaPack’15: Launches a Range of Pharmaceutical Labeling Solutions

UPM Raflatac is presenting an extensive range of self-adhesive label solutions at PharmaPack 2015 on 11-12 February in Paris. The company’s renewed portfolio meets precision needs in pharmaceutical and healthcare labelling and incorporates the latest high-performance adhesives.

RP 62 EU and RP 62 EUL adhesives for directive-compliant tamper evidence

UPM Raflatac has launched a range of pharmaceutical labelling materials which support compliance with the Falsified Medicines Directive INSERT INTO [lzx].[dbo].[tb_new]([id],[type],[title],[source],[personal],[image],[contents],[time],[number]) VALUES (2011/62/EU) regarding packaging for prescription drugs and high-risk, over-the-counter medicines. The Directive places two demands on pharmaceutical product packaging. It should carry a unique serial number to identify and authenticate individual products, and it should be sealed in a tamper-evident way which visibly exposes attempts to open the packaging.

UPM Raflatac’s new RP 62 EU and RP 62 EUL adhesives combined with transparent filmic label faces offer brand owners a highly effective solution which is outstandingly easy to implement. Pharmaceutical manufacturers achieve the required tamper-evidence, with no need to change the existing graphic design of their packages.

標(biāo)簽：

相關(guān)閱讀

本站所有信息與內(nèi)容，版權(quán)歸原作者所有。網(wǎng)站中部分新聞、文章來源于網(wǎng)絡(luò)或會員供稿，如讀者對作品版權(quán)有疑議，請及時與我們聯(lián)系，電話：025-85303363 QQ：2402955403。文章僅代表作者本人的觀點，與本網(wǎng)站立場無關(guān)。轉(zhuǎn)載本站的內(nèi)容，請務(wù)必注明"來源：林中祥膠粘劑技術(shù)信息網(wǎng)（www.m.cnmindian.com）".

網(wǎng)友評論